# US 2002/0058838 A1 · Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0058838 A1
- Document ID: US20020058838A1
- Status: Published application
- Kind: A1
- Application number: 09/995,782
- Filed: 2001-11-29
- Published: 2002-05-16
- Earliest claimed: 1993-02-23
- Assignees: Hoechst Aktiengesellschaft
- Inventors: Heinrich Englert; Dieter Mania; Jens Hartung; Heinz Gogelein; Joachim Kaiser; Wolfgang Linz; David Wettlaufer
- Web page: https://patentgrep.com/patent/US20020058838A1

## CPC

- C07C 311/46: Y being a hydrogen or a carbon atom
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/04: Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C07C 311/58: having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C 335/42: Sulfonylthioureas; Sulfonylisothioureas
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Benzenesulfonylureas and -thioureas of the formula I 1 where R(1) is H or (fluoro)methyl, R(2) is H, Hal or (fluoro) (mercapto)alk(oxy)yl, E is O or S; Y is —[CR(3)2]n—, where R(3)=H or alkyl and n=1-4, X is H, Hal or alkyl and Z is Hal, NO3 or alk(yl)oxy, are described. The compounds I are used for treatment of disturbances in cardiac rhythm and prevention of sudden cardiac death caused by arrhythmia, and can therefore be used an antiarrhythmics. They are particularly suitable for those cases where arrhythmias are a consequence of a narrowing of a coronary vessel, such as angina pectoris or acute cardiac infarction.

## Claims

### Claim 1

A substituted benzenesulfonylurea or -thiourea of the formula I
38
in which
R(1) is hydrogen, methyl, CH2F, CHF2 or trifluoromethyl,
R(2) is hydrogen, F, Cl, Br, I, (C1-C6)-alkyl, (C1-C6)-alkoxy, (C1-C6)-mercaptoalkyl, (C1-C6)-fluoroalkoxy or (C1-C6)-fluoroalkyl,
E is oxygen or sulfur,
Y is a hydrocarbon chain of the formulas
—[CR(3)2]n—
where R(3)=H or (C1-C2)-alkyl and n=1, 2, 3 or 4,
X is hydrogen, F, Cl, Br, I or (C1-C6)-alkyl and
Z is F, Cl, Br, NO2, (C1-C4)-alkoxy or (C1-C4)-alkyl.

### Claim 2 (depends on 1)

A compound of the formula I as claimed in claim 1, in which:
R(1) is hydrogen, methyl or trifluoromethyl,
R(2) is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy, (C1-C6)-mercaptoalkyl, (C1-C6)-fluoroalkyl, (C1-C6)-fluoroalkoxy or F, Cl, Br or I,
E is oxygen or sulfur,
Y is a hydrocarbon chain of the formula
—[CR(3)2]n—
where R(3)=H or (C1-C2)-alkyl and n=1, 2, 3 or 4,
X is hydrogen, F, Cl or (C1-C4)-alkyl and
Z is nitro, F, Cl, (C1-C4) -alkyl or (C1-C4)-alkoxy.

### Claim 3 (depends on 1)

A compound of the formula I as claimed in claim 1, in which:
R(1) is hydrogen or methyl, and
R(2) is hydrogen, fluorine or chlorine,
E is oxygen or sulfur,
Y is a hydrocarbon chain of the formula
—[R(3)2]n—
where R(3) us or (C1-C2)-alkyl and n=1, 2, 3 or 4,
X is hydrogen, F, Cl or (C1-C4)-alkyl, and
Z is chlorine, fluorine, (C1-C4)-alkyl or (C1-C4)-alkoxy.

### Claim 4 (depends on 1)

A compound of the formula I as claimed in claim 1, in which:
R(1) is hydrogen or methyl,
R(2) is (C1-C6)-fluoroalkyl, (C1-C6)-fluoroalkoxy or (C1-C6)-mercaptoalkyl,
E is oxygen or sulfur,
Y in a hydrocarbon radical of the formula:
—[CR(3)2]n—
where R(3)=H or (C1-C2)-alkyl and n=1, 2, 3 or 4,
X in hydrogen, F, Cl or (C1-C4)-alkyl and
Z is chlorine, fluorine, (C1-C4)-alkyl or (C1-C4)-alkoxy.

### Claim 5 (depends on 1)

A compound of the formula I as claimed in claim 1, in which:
R(1) is hydrogen or methyl,
R(2) is methoxy or methyl,
E is oxygen or sulfur,
Y is a substituted or unsubstituted hydrocarbon radical having two to three carbon atoms of the formula
—[CR(3)2]n—
where R(3)=H or methyl and n=2 or 3,
X is hydrogen, F, Cl or (C1-C3) -alkyl and
Z is chlorine or fluorine, (C1-C3)-alkyl or (C1-C3)-alkoxy.

### Claim 6 (depends on 1)

A process for the preparation of a compound I an claimed in claim 1, which comprises
(a) reacting an aromatic sulfonamide of the formula II or salts thereof of the formula III
39
with an R(1)-substituted isocyanate of the formula IV
R(1)—N=C=O IV
to give a substituted benzenesulfonylurea Ia, or
(b) preparing an unsubstituted benzenesulfonylurea Ia (R(1)=H)
40
by reaction of an aromatic benzenesulfonamide of the formula II or its salt III
with a trialkylsilyl isocyanate or silicon tetraisocyanate and hydrolysis of the primary silicon-substituted benzenesulfonylurea, or
(c) preparing a benzenesulfonylurea Ia
41
from an aromatic benzenesulfonamide II or its salt III from an R(1)-substituted trichloroacetamide of the formula V
42
in the presence of a base, or
d) reacting an aromatic sulfonamide of the formula II or salt thereof of the formula III
43
with an R(1)-substituted thioisocyanate of the formula VI
R(1)—N═C═S VI
to give a substituted benzenesulfonylthiourea lb.

### Claim 7 (depends on 1)

The use of a compound I an claimed in claim 1 for the preparation of a medicament for the treatment of disturbances in cardiac rhythm.

### Claim 8 (depends on 1)

The use of a compound I an claimed in claim 1 for the preparation of a medicament for prevention of sudden cardiac death.

### Claim 9 (depends on 1)

The use of a compound I an claimed in claim 1 for the preparation of a medicament for the treatment of ischemic conditions of the heart.

### Claim 10 (depends on 1)

The use of a compound I as claimed in claim 1 for the preparation of a scientific tool for inhibition of ATP-sensitive potassium channels.

### Claim 11

The use of a compound I for the preparation of a medicament for the treatment of weakened cardiac force.

### Claim 12

The use of a compound I for the preparation of a medicament for improving cardiac function following a heart transplant.

### Claim 13 (depends on 1)

A medicine comprising an active amount of a compound of the formula I as claimed in claim 1.
